Mechanism of action: two pathways for reducing clotting
All agents that reduce blood clotting share a common principle of action: they prevent thrombus formation. However, they achieve this goal through entirely different pathways. Globally, they can be divided into two major categories depending on their site of action and the state of the coagulation factors they affect.
The first pathway operates directly in the systemic circulation. Direct anticoagulants (with heparin as the benchmark representative) encounter coagulation factors right in the blood. A crucial detail is that these drugs inhibit already activated factors. In other words, enzymes that have already triggered the coagulation cascade are blocked and lose their activity. The main pharmacological targets for this group are activated factors IXa and Xa, as well as factor IIa, better known as thrombin.
The second pathway involves interfering with the creation of the factors themselves. Indirect anticoagulants (such as warfarin) have no effect on proteins already circulating in the blood. Their site of action is the liver. It is there that they disrupt the synthesis of new clotting factors. As a result of this action, fully functional inactive precursors—factors VII, IX, X, and factor II (prothrombin)—stop entering the blood. Gradually, their plasma reserves become depleted, and clotting decreases.
Detailed classification of direct anticoagulants
The group of direct-acting drugs is quite diverse. Within it, several subclasses are distinguished, each with its own strict molecular target and specific chemical structure.
- Direct thrombin (factor IIa) inhibitors. These drugs purposefully bind to thrombin and remove it from the coagulation cascade. This subclass includes hirudin preparations such as lepirudin and bivalirudin. Additionally, modern drug dabigatran belongs to direct thrombin inhibitors.
- Direct factor Xa inhibitors. These agents block activated factor X without affecting thrombin itself. A prominent and best-known representative of this narrow subclass is rivaroxaban.
- Factor Va and VIIIa inhibitors. The mechanism of action of this group differs from the previous ones. They do not merely bind to factors, but perform their proteolysis (destruction). This category includes drotrecogin alfa, which is a recombinant activated protein C.
Chemical classes of indirect anticoagulants
Since all indirect anticoagulants share a single site of action (they inhibit the synthesis of coagulation factors in liver tissues), they are conventionally classified not by targets, but by the chemical structure of the molecule. Traditionally, two main chemical groups are distinguished:
- Coumarin derivatives. This is the largest and most clinically utilized group. It includes the famous warfarin as well as acenocoumarol, which is frequently found in medical literature under the trade name sincumar.
- Indandione derivatives. The second group of drugs with a similar mechanism of action on hepatic synthesis. The main representative of indandione derivatives is phenindione, also known as phenilin.
Briefly: answers to topical questions
Which drugs belong to direct thrombin (factor IIa) inhibitors?
Hirudin preparations and dabigatran belong to direct thrombin (factor IIa) inhibitors.
- Hirudin preparations include lepirudin (recombinant hirudin) and bivalirudin. Lepirudin is administered intravenously, primarily for heparin-induced thrombocytopenia.
- Dabigatran is a direct inhibitor used as a prodrug (dabigatran etexilate) that binds directly to the catalytic active site of the enzyme.
Which drugs belong to direct factor Xa inhibitors?
Rivaroxaban, apixaban, and edoxaban belong to direct factor Xa inhibitors.
- Rivaroxaban blocks factor Xa in its free form and as part of the prothrombinase complex; it is administered once daily.
- Apixaban is a selective inhibitor prescribed twice daily.
- Edoxaban is administered at a dose of 60 mg once daily (with a possible reduction to 30 mg in specific populations).
What antidote is used for heparin overdose?
Protamine sulfate is used as a specific antidote for heparin overdose.
- Protamine sulfate binds to the anionic centers of heparin, forming an insoluble complex and chemically neutralizing its anticoagulant effect.
The drug is administered slowly intravenously in cases of serious bleeding. The dosage is calculated as 1 mg of protamine sulfate per 100 IU of heparin sodium. This antidote is less effective in low-molecular-weight heparin overdoses.
Which laboratory parameter is used to monitor warfarin therapy?
Warfarin therapy is monitored using the laboratory parameter INR (international normalized ratio).
- INR 2.0–2.5 is the target value for standard treatment.
- INR 3.0–4.0 is the target value for patients with prosthetic heart valves.
The first parameter check is performed 24–48 hours after initiating the drug. When switching a patient from low-molecular-weight heparins to warfarin, concurrent administration is required for the first 4–5 days under INR monitoring.
What specific side effects does heparin cause?
Unfractionated heparin therapy can cause a number of specific side effects.
- Heparin-induced thrombocytopenia can be early (benign) or late immune-mediated, which is accompanied by paradoxical thrombosis.
- Osteoporosis—the risk increases with prolonged use of the drug (more than 3 months).
- Hyperkalemia is a rare complication associated with the inhibition of aldosterone synthesis in the adrenal glands.
Reversible alopecia, elevated liver transaminases, and allergic reactions, including skin rash and arthralgia, are also possible.
What are the absolute contraindications to prescribing anticoagulants?
Long-term anticoagulant therapy is contraindicated in the following conditions:
- Severe bleeding associated with the gastrointestinal, pulmonary, or urogenital systems, if caused by an irreversible cause.
- Spontaneous intracranial or intraspinal bleeding if caused by an irreversible cause.
- Serious bleeding associated with recurrent trauma, when the cause of the trauma is untreatable.
In the prevention of thrombosis and ischemic stroke, the threat of hemorrhagic stroke is indicated as a contraindication.
Direct anticoagulants work in the blood with already activated factors (their designation contains the letter "a": IXa, Xa, IIa). Indirect anticoagulants act via the liver, disrupting the synthesis of baseline factors (without the letter "a": VII, IX, X, II).
Class and exam questions
What is the general principle of action of all anticoagulants?
The general principle of action of these pharmacological agents boils down to reducing blood clotting. This is achieved either by inhibiting already activated coagulation factors directly in the bloodstream, or by disrupting the synthesis of new factors in the liver.
Which specific clotting factors are blocked by heparin?
Heparin is a classic direct anticoagulant. Its pharmacological targets are factors that have already transitioned into an active state. These include factors IXa, Xa, and IIa (thrombin).
How does warfarin work and which factors does it affect?
Warfarin belongs to the group of indirect anticoagulants (coumarin derivatives). It does not work in the blood, but acts in the liver, where it inhibits the synthesis of factors VII, IX, X, and II (prothrombin).
What is drotrecogin alfa and what is its mechanism?
Drotrecogin alfa is a recombinant activated protein C. It belongs to direct anticoagulants and works by performing proteolysis (cleavage) of activated factors Va and VIIIa.
What else to study on this topic
- Mechanism of proteolysis of factors VIIIa and Va by recombinant protein C (drotrecogin alfa).
- Pharmacological properties of coumarin derivatives (acenocoumarol, warfarin).
- Specific effects of indandione derivatives (phenindione).
- Direct factor Xa inhibitors using the example of rivaroxaban.
- Hirudin preparations: specifics of use of lepirudin and bivalirudin.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Anticoagulants" and another 5,304 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs affecting hemostasis and thrombosis"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.